0% found this document useful (0 votes)
22 views12 pages

Lab Report New

Uploaded by

ayushawasthi842
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
22 views12 pages

Lab Report New

Uploaded by

ayushawasthi842
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Barcode No : E91553695 Lab No : KAN2509060314

Patient Name : Mrs.ARCHANA AWASTHI Reg Date : 06/Sep/2025 06:28PM


Age/Gender : 36 Y 0 M 0 D /F Sample Coll. Date : 06/Sep/2025 06:28PM
Refered By : SELF Sample Rec.Date : 06/Sep/2025 07:03PM
Ref. Lab/Hosp : Report Date : 06/Sep/2025 08:03PM
Client Code/Name :AP033545 Ansh Collection Centre
Client Add. : MIC -29 Vasudha Vihar -1

DEPARTMENT OF HAEMATOLOGY
Test Name Result Unit Bio. Ref. Range Method

ACCUPROBE PLATINUM PANEL


Complete Blood Count (CBC)+ESR
Sample Type : WHOLE BLOOD EDTA (2 ML)
Haemoglobin 10.6 gm/dl 12.0-15.0 Cyanide free
TLC (Total Leucocyte Count) 9.68 th/cumm 4.0-10.0 Coulter Principle
DIFFERENTIAL LEUCOCYTE COUNT
Polymorphs 74.6 % 40-80 VCSn Technology
Lymphocytes 19.0 % 20-40 Flowcytometry
Eosinophils 1.8 % 1-6 Flowcytometry
Monocytes 4.5 % 2-10 Flowcytometry
Basophils 0.1 % 0-1 Flowcytometry
Absolute Neutrophil Count 7221.28 /cumm 2000-7000 Flow cytometry
Absolute Lymphocyte Count. 1839.2 /cumm 1000.0 - 3000.0 Calculated
Absolute Eosinophil Count 174.24 /cumm 20-500 VCSn Technology
Absolute Monocyte Count 435.6 /cumm 20-1000 Flow cytometry
Absolute Basophils Count 9.68 /cumm 20-100 VCSn Technology
RBC 3.72 millions/cmm 3.8-4.8 Impedance
HCT 33.5 % 36-46 Calculated
MCV 90.05 fl 83-101 Calculated
MCH 28.49 pg 27-32 Calculated
MCHC 31.64 g/dl 31.5-34.5 Calculated
Platelet Count 157 thou/µL 150-410 Impedance
MPV 14.8 fl 7.4-10.4 Calculated
RDW- CV 15.4 % 11.6-14.0 Whole Blood EDTA, Flowcytometry
RDW- SD 48.5 fl 35-56 Whole Blood EDTA, Flowcytometry
PCT 0.16 % 0.10-0.28 Flow Cytometry
PDW 16.4 fl 9.0-17.0
Mentzer Index 24.21 Ratio N/A
RDWI 372.79
Green and King 117.81
Neutrophil - Lymphocyte Ratio 3.93 Ratio Calculated

This test was performed:Accuprobe Diagnostics:86/275-A3 Afim Kothi G.T Road Kanpur-208003

Page 1 of 12
Barcode No : E91553695 Lab No : KAN2509060314
Patient Name : Mrs.ARCHANA AWASTHI Reg Date : 06/Sep/2025 06:28PM
Age/Gender : 36 Y 0 M 0 D /F Sample Coll. Date : 06/Sep/2025 06:28PM
Refered By : SELF Sample Rec.Date : 06/Sep/2025 07:03PM
Ref. Lab/Hosp : Report Date : 06/Sep/2025 08:03PM
Client Code/Name :AP033545 Ansh Collection Centre
Client Add. : MIC -29 Vasudha Vihar -1

DEPARTMENT OF HAEMATOLOGY
Test Name Result Unit Bio. Ref. Range Method

(NLR)
Lymphocyte - Monocyte Ratio 4.22 Ratio Calculated
(LMR)
Platelet - Lymphocyte Ratio (PLR) 85.36 Ratio Calculated
ESR [Westergren] 32 mm/ 1 hr 0 -20 Modified Westergren

Kindly correlate clinically. Advise for recheck from fresh sample in case, it is not correlation clinically, to rule out any pre-analytical error.
Referrance range according to Practical Haematology, Dacie & Lewis, 12th edition, 2012.

This test was performed:Accuprobe Diagnostics:86/275-A3 Afim Kothi G.T Road Kanpur-208003

Page 2 of 12
Barcode No : E91553695 Lab No : KAN2509060314
Patient Name : Mrs.ARCHANA AWASTHI Reg Date : 06/Sep/2025 06:28PM
Age/Gender : 36 Y 0 M 0 D /F Sample Coll. Date : 06/Sep/2025 06:28PM
Refered By : SELF Sample Rec.Date : 06/Sep/2025 07:03PM
Ref. Lab/Hosp : Report Date : 06/Sep/2025 07:53PM
Client Code/Name :AP033545 Ansh Collection Centre
Client Add. : MIC -29 Vasudha Vihar -1

DEPARTMENT OF HAEMATOLOGY
Test Name Result Unit Bio. Ref. Range Method

HbA1c (Glycated hemoglobin)


Sample Type : WHOLE BLOOD EDTA (2 ML)
Glycosylated Hb (HbA1c) 4.9 % 4.2-6.5 HPLC
Average Glucose 94 mg/dl 73-140
Ref Range for HBA1c
Non Diabetic: < 5.7 %
Pre-Diabetic: 5.7 - 6.5 %
Diabetic: > 6.5 %
Remark: Hemoglobin A1c criteria for diagnosing diabetes have not been established for patients who are <18 years of age.

HbA1c goals in treatment of diabetes:


Ages 0-6 years: 7.6% - 8.4%
Ages 6-12 years: <8%
Ages 13-19 years: <7.5%
Adults: <7%
COMMENT:
The Glycosylated Hemoglobin (HbA1c or A1c) test evaluates the average amount of glucose in the blood over the last 2 to 3 months. This test is used to
monitor treatment in someone who has been diagnosed with diabetes. It helps to evaluate how well the person's glucose levels have been controlled by
treatment over time. This test may be used to screen for and diagnose diabetes or risk of developing diabetes. Depending on the type of diabetes that a
person has, how well their diabetes is controlled, and on doctor recommendations, the HbA1c test may be measured 2 to 4 times each year. The
American Diabetes Association recommends HbA1c testing in diabetics at least twice a year. When someone is first diagnosed with diabetes or if control
is not good, HbA1c may be ordered more frequently.
Note: If a person has anemia, few type of hemoglobinopathy, hemolysis, or heavy bleeding, HbA1c test results may be falsely low. If someone is iron-
deficient, the HbA1c level may be increased. If a person has had a recent blood transfusion, the HbA1c may be inaccurate and may not accurately
reflect glucose control for 2 to 3 months..

This test was performed:Accuprobe Diagnostics:86/275-A3 Afim Kothi G.T Road Kanpur-208003

Page 3 of 12
Barcode No : E91553695 Lab No : KAN2509060314
Patient Name : Mrs.ARCHANA AWASTHI Reg Date : 06/Sep/2025 06:28PM
Age/Gender : 36 Y 0 M 0 D /F Sample Coll. Date : 06/Sep/2025 06:28PM
Refered By : SELF Sample Rec.Date : 06/Sep/2025 07:03PM
Ref. Lab/Hosp : Report Date : 06/Sep/2025 07:53PM
Client Code/Name :AP033545 Ansh Collection Centre
Client Add. : MIC -29 Vasudha Vihar -1

DEPARTMENT OF HAEMATOLOGY
Test Name Result Unit Bio. Ref. Range Method

This test was performed:Accuprobe Diagnostics:86/275-A3 Afim Kothi G.T Road Kanpur-208003

Page 4 of 12
Barcode No : F91553695 Lab No : KAN2509060314
Patient Name : Mrs.ARCHANA AWASTHI Reg Date : 06/Sep/2025 06:28PM
Age/Gender : 36 Y 0 M 0 D /F Sample Coll. Date : 06/Sep/2025 06:28PM
Refered By : SELF Sample Rec.Date : 06/Sep/2025 07:07PM
Ref. Lab/Hosp : Report Date : 07/Sep/2025 08:49AM
Client Code/Name :AP033545 Ansh Collection Centre
Client Add. : MIC -29 Vasudha Vihar -1

DEPARTMENT OF .IMMUNO BIOCHEMISTRY-1


Test Name Result Unit Bio. Ref. Range Method

Glucose Fasting (Blood Glucose Fasting)


Sample Type : FLUORIDE PLASMA_F
Blood Sugar Fasting 89 mg/dL 70-100 Hexokinase

COMMENTS:
Fasting Blood Sugar/Glucose test. A blood sample will be taken after an overnight fast. A fasting blood sugar level less than 100 mg/dL
is normal. A fasting blood sugar level from 100 to 125 mg/dL is considered prediabetes. If it's 126 mg/dL or higher on two separate tests,
you have diabetes. (American Diabetes Association)

This test was performed:Accuprobe Diagnostics:86/275-A3 Afim Kothi G.T Road Kanpur-208003

Page 5 of 12
Barcode No : S91553695 Lab No : KAN2509060314
Patient Name : Mrs.ARCHANA AWASTHI Reg Date : 06/Sep/2025 06:28PM
Age/Gender : 36 Y 0 M 0 D /F Sample Coll. Date : 06/Sep/2025 06:28PM
Refered By : SELF Sample Rec.Date : 06/Sep/2025 07:04PM
Ref. Lab/Hosp : Report Date : 07/Sep/2025 08:49AM
Client Code/Name :AP033545 Ansh Collection Centre
Client Add. : MIC -29 Vasudha Vihar -1

DEPARTMENT OF .IMMUNO BIOCHEMISTRY-1


Test Name Result Unit Bio. Ref. Range Method

Lipid Profile
Sample Type : Serum (2ml)
Cholesterol 234.0 mg/dl <200 CHOD-PAP Enzymatic
Triglyceride 144.0 mg/dl <150 Colorimetric
HDL-Cholesterol 58.3 mg/dL 40-60 Homogeneous Enz.Colorimetric
LDL Cholesterol 146.9 mg/dl 0-100 Calculated
VLDL Cholesterol 28.8 mg/dl 5 - 40 Calculated
LDL / HDL Ratio 2.52 Ratio 0 - 3.55 Calculated
HDL / LDL Ratio 0.40 Ratio >0.3 Calculated
Chol / HDL Ratio 4.01 Ratio 0 - 4.97 Calculated
Non-HDL Cholesterol 175.7 mg/dl <130 Calculated
Lipids are a group of fats and fat-like substances that are important constituents of cells and sources of energy. The lipid profile is used as part of a cardiac risk assessment to help determine an individual's risk
of heart disease. It is recommended that healthy adults with no other risk factors for heart disease be tested with a fasting lipid profile once every four to six years. If other risk factors are present or if previous
testing revealed a high cholesterol level in the past, more frequent testing is recommended.

TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150


BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199

HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499

HIGH 160-189 VERY HIGH >500

VERY HIGH >190


*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES

This test was performed:Accuprobe Diagnostics:86/275-A3 Afim Kothi G.T Road Kanpur-208003

Page 6 of 12
Barcode No : S91553695 Lab No : KAN2509060314
Patient Name : Mrs.ARCHANA AWASTHI Reg Date : 06/Sep/2025 06:28PM
Age/Gender : 36 Y 0 M 0 D /F Sample Coll. Date : 06/Sep/2025 06:28PM
Refered By : SELF Sample Rec.Date : 06/Sep/2025 07:04PM
Ref. Lab/Hosp : Report Date : 07/Sep/2025 08:58AM
Client Code/Name :AP033545 Ansh Collection Centre
Client Add. : MIC -29 Vasudha Vihar -1

DEPARTMENT OF .IMMUNO BIOCHEMISTRY-1


Test Name Result Unit Bio. Ref. Range Method

Liver Panel (LFT)


Sample Type : Serum (2ml)
Total Bilirubin. 0.295 mg/dl 0.0-1.2 DCA
Conjugated Bilirubin 0.198 mg/dl 0.0-0.3 DCA
Unconjugated Bilirubin 0.1 mg/dL 0.2-0.7 Calculated
SGOT (AST) 29.6 IU/L 0 -32 OptimizedUVtestwithIFCC
SGPT (ALT) 20.9 IU/L 0-33 OptimizedUVtestwithIFCC
Alk.Phosphatase 106.0 IU/L 30-104 IFCC
T.Protein 9.15 gm/dl 6.4-8.3 Biuret
Albumin 5.34 gm/dl 3.5-5.2 Bromocresol Green
Globulin 3.81 gm/dl 2.5-3.8 Calculated
A/G Ratio 1.4 Ratio 1.30 - 1.70 Calculated
Gamma G.T. 22.2 IU/L <40 Kinetic with IFCC
SGOT/SGPT Ratio 1.42 Ratio 0-5 Calculated

Note: Rechecked Value, Kindly correlate clinically.

Comment:

A liver panel (Liver function test) or one or more of its component tests may be used to help diagnose liver disease if a person has symptoms that indicate possible liver
dysfunction. If a person has a known condition or liver disease, testing may be performed at intervals to monitor liver status and to evaluate the effectiveness of any
treatments.

This test was performed:Accuprobe Diagnostics:86/275-A3 Afim Kothi G.T Road Kanpur-208003

Page 7 of 12
Barcode No : S91553695 Lab No : KAN2509060314
Patient Name : Mrs.ARCHANA AWASTHI Reg Date : 06/Sep/2025 06:28PM
Age/Gender : 36 Y 0 M 0 D /F Sample Coll. Date : 06/Sep/2025 06:28PM
Refered By : SELF Sample Rec.Date : 06/Sep/2025 07:04PM
Ref. Lab/Hosp : Report Date : 06/Sep/2025 08:26PM
Client Code/Name :AP033545 Ansh Collection Centre
Client Add. : MIC -29 Vasudha Vihar -1

DEPARTMENT OF .IMMUNO BIOCHEMISTRY-1


Test Name Result Unit Bio. Ref. Range Method

Vitamin B12 (Cynocobalamin)


Sample Type : Serum (2ml)
Vitamin B12 Level 152 pg/ml 197-711 Electro Chemi Luminescent Immuno
Assay
Comment:
Vitamin B12 (cobalamin) is an important water-soluble vitamin. In contrast to other water-soluble vitamins it is not excreted quickly in the urine, but rather accumulates
and is stored in the liver, kidney and other body tissues. Humans obtain Vitamin B12 exclusively from animal dietary sources, such as meat, eggs and milk. As a result,
a vitamin B12 deficiency may not manifest itself until after 5 or 6 years of a diet supplying inadequate amounts. Vitamin B12 functions as a methyl donor and works
with folic acid in the synthesis of DNA and red blood cells and is vitally important in maintaining the health of the insulation sheath (myelin sheath) that surrounds
nerve cells. Preservatives such as fluorides & ascorbic acid interfere with this assay. Excessive exposure of the specimen to light may alter Vitamin B12 result.
Kindly correlate with clinical conditions.

This test was performed:Accuprobe Diagnostics:86/275-A3 Afim Kothi G.T Road Kanpur-208003

Page 8 of 12
Barcode No : S91553695 Lab No : KAN2509060314
Patient Name : Mrs.ARCHANA AWASTHI Reg Date : 06/Sep/2025 06:28PM
Age/Gender : 36 Y 0 M 0 D /F Sample Coll. Date : 06/Sep/2025 06:28PM
Refered By : SELF Sample Rec.Date : 06/Sep/2025 07:04PM
Ref. Lab/Hosp : Report Date : 07/Sep/2025 08:51AM
Client Code/Name :AP033545 Ansh Collection Centre
Client Add. : MIC -29 Vasudha Vihar -1

DEPARTMENT OF .IMMUNO BIOCHEMISTRY-1


Test Name Result Unit Bio. Ref. Range Method

Vitamin D (25 OH) Total


Sample Type : Serum (2ml)
Vitamin D 25 OH 16.30 ng/mL Deficeincy: Electro Chemi Luminescent Immuno
<20.0~Insufficient: 21- Assay
29~Sufficient: 30-100
Comments:
This test is used to determine the levels of 25-hydroxy-vitamin D and is used to determine if bone weakness, bone malformation, or abnormal metabolism of calcium is occurring as a result of a
deficiency or excess of vitamin D. Since vitamin D is a fat-soluble vitamin and is absorbed from the intestine like a fat, vitamin D is also s used to monitor individuals with diseases that interfere
with fat absorption, such as cystic fibrosis and Crohn's disease, and in patients who have had gastric bypass surgery and may not be able to absorb enough Vitamin D. Vitamin D is also used to
determine effectiveness of treatment when vitamin D, calcium, phosphorus, and/or magnesium supplementation is prescribed. Reasons for suboptimal 25-OH-VitD levels include lack of sunshine
exposure, inadequate intake; malabsorption eg, due to Celiac disease); depressed hepatic vitamin D 25-hydroxylase activity, secondary to advanced liver disease; and enzyme-inducing drugs, in
particular many antiepileptic drugs, including phenytoin, phenobarbital, and carbamazepine, that increase 25-OH-VitD metabolism. In contrast to the high prevalence of 25-OH-VitD deficiency,
hypervitaminosis D is rare, and is only seen after prolonged exposure to extremely high doses of vitamin D. When it occurs, it can result in severe hypercalcemia and hyperphosphatemia.
Kindly correlate with clinical conditions

This test was performed:Accuprobe Diagnostics:86/275-A3 Afim Kothi G.T Road Kanpur-208003

Page 9 of 12
Barcode No : S91553695 Lab No : KAN2509060314
Patient Name : Mrs.ARCHANA AWASTHI Reg Date : 06/Sep/2025 06:28PM
Age/Gender : 36 Y 0 M 0 D /F Sample Coll. Date : 06/Sep/2025 06:28PM
Refered By : SELF Sample Rec.Date : 06/Sep/2025 07:04PM
Ref. Lab/Hosp : Report Date : 07/Sep/2025 01:21AM
Client Code/Name :AP033545 Ansh Collection Centre
Client Add. : MIC -29 Vasudha Vihar -1

DEPARTMENT OF .IMMUNO BIOCHEMISTRY-1


Test Name Result Unit Bio. Ref. Range Method

Thyroid Profile-I [T3,T4,TSH]


Sample Type : Serum (2ml)
T3 (Triiodothyronine) 120 ng/dl 80-200 ECLIA
T4 (Thyroxine) 6.24 ug/dl 5.1-14.1 ECLIA
TSH (3rd Gen, Ultrasensitive) 6.52 uIU/mL 0.13-6.33 ECLIA

Comments:
Our reference range applies the central 95th interval (2.5th – 97.5th quantile) according to the CLSI/IFCC guidelines EP28-A3c.

A circadian variation in serum TSH in healthy subjects is well documented. TSH level is reaching peak levels between 2-4 am and at a minimum between 6-10 pm. The variation

is of the order of 50%, hence time of the day has influence on the value of TSH.

TSH levels between 6.3 and 15.0 may represent subclinical or compensated hypothyroidism or show considerable physiological & seasonal variation, suggest clinical correlation

or repeat testing with fresh sample.

TSH levels may be transiently altered because of non-thyroid illness, like severe infection, renal disease, liver disease, heart disease, severe burns, trauma, surgery etc. Few

drugs also altered the TSH values.

A high TSH result often means an underactive thyroid gland caused by failure of the gland (hypothyroidism). A low TSH result can indicate an overactive thyroid gland

(hyperthyroidism) or damage to the pituitary gland that prevents it from producing TSH.

Below mentioned are the guidelines for age reference ranges for T3,T4 and TSH results:
Age Total T3 (ng/dl) Total T4 (µg/dl) TSH (µlU/ml)
1 - 6 days 73 - 288 5.04 - 18.5 0.7 - 15.0
6 days - 3 months 80 - 275 5.41 - 17.0 0.72 - 11.0
4 - 12 months 86 - 265 5.67 - 16.0 0.73 - 8.35
1 - 6 years 92 - 248 5.95 - 14.7 0.70 - 5.97
7 - 11 years 93 - 231 5.99 - 13.8 0.60 - 5.84
12 - 20 years 91 - 218 5.91 - 13.2 0.51 - 6.50
>20 years 80-200 5.1-14.1 0.13 - 6.33
TSH Level in pregnancy
First Trimester 0.10 – 2.5 µlU/ml
Second Trimester 0.20 – 3.0 µlU/ml
Third Trimester 0.30 – 3.0 µlU

This test was performed:Accuprobe Diagnostics:86/275-A3 Afim Kothi G.T Road Kanpur-208003

Page 10 of 12
Barcode No : S91553695 Lab No : KAN2509060314
Patient Name : Mrs.ARCHANA AWASTHI Reg Date : 06/Sep/2025 06:28PM
Age/Gender : 36 Y 0 M 0 D /F Sample Coll. Date : 06/Sep/2025 06:28PM
Refered By : SELF Sample Rec.Date : 06/Sep/2025 07:04PM
Ref. Lab/Hosp : Report Date : 07/Sep/2025 08:49AM
Client Code/Name :AP033545 Ansh Collection Centre
Client Add. : MIC -29 Vasudha Vihar -1

DEPARTMENT OF .IMMUNO BIOCHEMISTRY-1


Test Name Result Unit Bio. Ref. Range Method

Iron Panel Basic


Sample Type : Serum (2ml)
Iron 60.7 ug/dl 33-193 FerroZine without deproteinization
UIBC 275 ug/dL 63 - 433 Biochemical
TIBC 335.7 ug/dL 250-400 Biochemical
Transferrin Saturation 18.08 % 15-55 Calculated

COMMENT:
Serum iron measures the amount of circulating iron that is bound to transferrin. Clinicians order this laboratory test
when they are concerned about iron deficiency, which can cause anemia and other problems.
Total iron-binding capacity The test measures the extent to which iron-binding sites in the serum can be saturated.
Because the iron-binding sites in the serum are almost entirely dependent on circulating transferrin, this is really
an indirect measurement of the amount of transferrin in the blood. Taken together with serum iron and percent
transferrin saturation clinicians usually perform this test when they are concerned about anemia, iron deficiency or
iron deficiency anemia. However, because the liver produces transferrin, liver function must be considered when
performing this test. It can also be an indirect test of liver function, but is rarely used for this purpose.

This test was performed:Accuprobe Diagnostics:86/275-A3 Afim Kothi G.T Road Kanpur-208003

Page 11 of 12
Barcode No : S91553695 Lab No : KAN2509060314
Patient Name : Mrs.ARCHANA AWASTHI Reg Date : 06/Sep/2025 06:28PM
Age/Gender : 36 Y 0 M 0 D /F Sample Coll. Date : 06/Sep/2025 06:28PM
Refered By : SELF Sample Rec.Date : 06/Sep/2025 07:04PM
Ref. Lab/Hosp : Report Date : 07/Sep/2025 08:58AM
Client Code/Name :AP033545 Ansh Collection Centre
Client Add. : MIC -29 Vasudha Vihar -1

DEPARTMENT OF .IMMUNO BIOCHEMISTRY-1


Test Name Result Unit Bio. Ref. Range Method

Kidney Panel-2
Sample Type : Serum (2ml)
Blood Urea 19.2 mg/dL 15-40.0 Urease, GLDH
Serum Creatinine. 0.91 mg/dL 0.5-0.9 Jaffes
Uric Acid 3.48 mg/dl 2.4 - 5.7 Enzymatic colorimetry
Sodium 139 mmol /L 135 - 148 Ion Selective Electrode
Potassium 4.12 mmol /L 3.7-5.5 Ion Selective Electrode
Chloride 103 mmol/L 98-107 Ion Selective Electrode
Calcium. 9.25 mg/dL 8.6-10.0 NM-BAPTA
Phosphorus Serum 4.50 mg/dl 2.5-4.5 MolybdateUV
BUN (Blood Urea Nitrogen ) 8.97 mg/dL 6.0-20.0 Calculated
BUN/Creatinine Ratio 9.9 Ratio 10-20 Calculated
Urea/Creatinine Ratio 21.19 Ratio Calculated
eGFR (estimated Glomerular 74.84 mL/min/1.73 >60 Calculated
Filtration Rate) m2

The National Kidney Foundation recommends using the Estimated GFR using MDRD Creatinine Equation (2021)
to estimate GFR. (http://surl.li/lwaub)

Kindly correlate clinically. Advise for recheck from fresh sample in case, it is not correlation clinically, to rule out
any pre-analytical error.

This test was performed:Accuprobe Diagnostics:86/275-A3 Afim Kothi G.T Road Kanpur-208003

Page 12 of 12

You might also like